Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease

被引:27
|
作者
von Leupoldt, Andreas [1 ,2 ]
Fritzsche, Anja [1 ]
Trueba, Ana F. [3 ]
Meuret, Alicia E. [3 ]
Ritz, Thomas [3 ]
机构
[1] Univ Hamburg, Dept Psychol, D-20146 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany
[3] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA
基金
美国国家卫生研究院;
关键词
Behavioral medicine; Chronic obstructive pulmonary disease; COPD; Psychosocial; Treatment; QUALITY-OF-LIFE; RESPIRATORY SINUS ARRHYTHMIA; DISTRACTIVE AUDITORY-STIMULI; RANDOMIZED CONTROLLED-TRIAL; DYSPNEA SELF-MANAGEMENT; SMOKING-CESSATION; EXERCISE TOLERANCE; CLINICAL-PRACTICE; LUNG-FUNCTION; DEPRESSIVE SYMPTOMS;
D O I
10.1007/s12160-012-9348-7
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disease and associated with considerable individual and socioeconomic burden. Recent research started examining the role of psychosocial factors for course and management of the disease. Purpose This review provides an overview on recent findings on psychosocial factors and behavioral medicine approaches in COPD. Results Research has identified several important psychosocial factors and effective behavioral medicine interventions in COPD. However, there is considerable need for future research in this field. Conclusions Although beneficial effects of some behavioral medicine interventions have been demonstrated in COPD, future research efforts are necessary to study the effects of distinct components of these interventions, to thoroughly examine promising but yet not sufficiently proven interventions, and to develop new creative interventions.
引用
收藏
页码:52 / 65
页数:14
相关论文
共 50 条
  • [1] Integrative Medicine for Respiratory Conditions Asthma and Chronic Obstructive Pulmonary Disease
    Yeh, Gloria Y.
    Horwitz, Randy
    MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (05) : 925 - +
  • [2] Precision medicine in chronic obstructive pulmonary disease
    Halpin, David M. G.
    CHINESE MEDICAL JOURNAL, 2022, 135 (10) : 1156 - 1162
  • [3] Personalized medicine and chronic obstructive pulmonary disease
    Wouters, E. F. M.
    Wouters, B. B. R. A. F.
    Augustin, I. M. L.
    Franssen, F. M. E.
    CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (03) : 241 - 246
  • [4] DETERMINATION OF CLINICAL PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A NEW TREATMENT APPROACH
    Avdeev, S. N.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (03) : 66 - 74
  • [5] The psychology of chronic obstructive pulmonary disease
    von Leupoldt, Andreas
    Kenn, Klaus
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (05) : 458 - 463
  • [6] Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches
    Zhou, Hai-Xia
    Ou, Xue-Mei
    Tang, Yong-Jiang
    Wang, Lan
    Feng, Yu-Lin
    CHINESE MEDICAL JOURNAL, 2015, 128 (21) : 2952 - 2959
  • [7] Supporting smoking cessation in chronic obstructive pulmonary disease with behavioral intervention: a randomized controlled trial
    Lou, Peian
    Zhu, Yanan
    Chen, Peipei
    Zhang, Pan
    Yu, Jiaxi
    Zhang, Ning
    Chen, Na
    Zhang, Lei
    Wu, Hongmin
    Zhao, Jing
    BMC FAMILY PRACTICE, 2013, 14
  • [8] Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap
    Lau, Edmund M. T.
    Roche, Nicole A.
    Reddel, Helen K.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 449 - 455
  • [9] Precision Approaches to Chronic Obstructive Pulmonary Disease Management
    Moll, Matthew
    Silverman, Edwin K.
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 247 - 262
  • [10] Emerging drugs in chronic obstructive pulmonary disease
    Seifart, Carola
    Vogelmeier, Claus
    EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (01) : 181 - 194